Colestid

Colestid is a brand name of colestipol, approved by the FDA in the following formulation(s):

COLESTID (colestipol hydrochloride - granule; oral)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: September 22, 1995
  
  Strength(s): 5GM/PACKET ^[RLD][AB], 5GM/SCOOPFUL ^[AB]

COLESTID (colestipol hydrochloride - tablet; oral)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: July 19, 1994
  
  Strength(s): 1GM ^[RLD][AB]

Has a generic version of Colestid been approved?

A generic version of Colestid has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Colestid and have been approved by the FDA:

colestipol hydrochloride granule; oral

• 
  Manufacturer: IMPAX LABS
  
  Approval date: May 2, 2006
  
  Strength(s): 5GM/PACKET ^[AB], 5GM/SCOOPFUL ^[AB]

colestipol hydrochloride tablet; oral

• 
  Manufacturer: IMPAX LABS
  
  Approval date: October 24, 2006
  
  Strength(s): 1GM ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Colestid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Tableting of colestipol hydrochloride
  Patent 5,490,987
  Issued: February 13, 1996
  Inventor(s): Shen; Robert W. & Price; Jeffrey E.
  Assignee(s): The Upjohn Company
  The present invention provides a novel formulation of matter and a novel process for making it. In particular, the present invention provides unique and novel 1000 mg tablets of Colestipol hydrochloride having the advantageous properties of hardness and low friability and a novel process for making such tablets.
  
  Patent expiration dates:
  
  
  • February 13, 2013
    
    ✓ 
    Drug product
  
  

See also...

• Colestid Consumer Information (Wolters Kluwer)
• Colestid Granules Consumer Information (Wolters Kluwer)
• Colestid Consumer Information (Cerner Multum)
• Colestid Advanced Consumer Information (Micromedex)
• Colestid AHFS DI Monographs (ASHP)
• Colestipol Consumer Information (Wolters Kluwer)
• Colestipol Granules Consumer Information (Wolters Kluwer)
• Colestipol Consumer Information (Cerner Multum)
• Colestipol Advanced Consumer Information (Micromedex)
• Colestipol Hydrochloride AHFS DI Monographs (ASHP)